About: SARS-CoV-2 infection in children

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: SARS-CoV-2 infection in children Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	SARS-CoV-2 infection in children
source	Medline; PMC; WHO
abstract	SARS-CoV-2, a RNA virus that emerged in December 2019 in the city of Wuhan in China and took hold of the whole world, affects children as well as all age groups. In our country, we started to observe the first cases by March 2020. SARS-CoV-2, which is transmitted by droplets and by way of contact with surfaces contaminated by these droplets, is generally transmitted to children from adults through close contact. There is no proven information about other transmission routes such as fecal-oral transmission. Similar to adults, the primary symptoms at presentation include fever, cough, sore throat, malaise, nasal discharge, and rarely, vomiting and diarrhea in children. Although the majority of pediatric patients are asymptomatic or have a mild clinical course, severe cases have been reported in children with underlying chronic diseases. There is currently no specific antiviral treatment against the SARS-CoV-2 virus. Supportive treatment is recommended in children with a mild course, and some treatments are recommended in children with comorbidities or in children who are observed to have a more severe course. Asymptomatic pediatric patients or pediatric patients who have a mild course constitute an important group in terms of transmission of the infection to the advanced age group who carry high risk. Prevention of infection is very important in terms of reducing new cases and alleviating the load on the healthcare system. In order to prevent transmission of SARS-CoV-2, hygienic rules should be pursued in the community, social distancing should be observed, and the family members and contacts of patients who have been diagnosed should be screened and isolated.
has issue date	2020-06-19(xsd:dateTime)
bibo:doi	10.14744/turkpediatriars.2020.20270
bibo:pmid	32684754
has license	cc-by-nc-sa
sha1sum (hex)	ae31512037e143a92212253e14ec1a1d549e2435
schema:url	https://doi.org/10.14744/turkpediatriars.2020.20270
resource representing a document's title	SARS-CoV-2 infection in children
has PubMed Central identifier	PMC7344135
has PubMed identifier	32684754
schema:publication	Turk Pediatri Ars
resource representing a document's body	covid:ae31512037e143a92212253e14ec1a1d549e2435#body_text
is schema:about of	named entity 'FUNDING' named entity 'Critical Review' named entity 'infection' named entity 'April 14' named entity 'fecal-oral transmission' named entity 'diabetes' named entity 'pediatric patients' named entity 'ECG' named entity 'bronchoalveolar lavage' named entity 'COVID' named entity 'sensitivity and specificity' named entity 'supportive treatment' named entity 'COVID' named entity 'granulocyte colony-stimulating factor' named entity 'coronavirus' named entity 'toxic shock syndrome' named entity 'COVID-19' named entity 'malaise' named entity 'United Kingdom' named entity 'myocarditis' named entity 'asymptomatic' named entity 'diarrhea' named entity 'leukocyte count' named entity 'symptom' named entity 'pediatric patients' named entity 'white cells' named entity 'Wuhan' named entity 'CRP' named entity 'acute leukemia' named entity 'renal disease' named entity 'SARS-CoV-2' named entity 'CRP' named entity 'COVID-19' named entity 'SARS-CoV-2' named entity 'asymptomatic' named entity 'epidemiologic' named entity 'immunoglobulin' named entity 'controlled studies' named entity 'January 11' named entity 'COVID' named entity 'antiinflammatory' named entity 'ferritin' named entity 'lopinavir/ritonavir' named entity 'antiviral agents' named entity 'critically ill patients' named entity 'malaise' named entity 'disease control' named entity 'vomiting' named entity 'disinfectants' named entity 'chloroquine' named entity 'infectivity' named entity 'influenza' named entity 'asymptomatic' named entity 'rapid test' named entity 'social distance' named entity 'Coronaviruses' named entity 'COVID' named entity 'stay alive' named entity 'oropharyngeal' named entity 'asymptomatic carriers' named entity 'cough' named entity 'macrophage' named entity 'virus' named entity 'headache' named entity 'IL-6' named entity 'comorbidities' named entity 'self-limiting' named entity 'RNA virus' named entity 'IL-7' named entity 'COVID' named entity 'ACE-2' named entity 'vaccine' named entity 'SARS-CoV-2' named entity 'endosome' named entity 'SARS-CoV-2' named entity 'ACE-2' named entity 'favipiravir' named entity 'upper respiratory tract' named entity 'fever' named entity 'MERS-CoV' named entity 'inotropic' named entity 'tablets'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software